Construction and Validation of a Potent Epigenetic Modification-Related Prognostic Signature for Osteosarcoma Patients

Figure 7

The risk score in two groups divided by clinical characteristics. (a–c) TARGET dataset; (d–f) GEO dataset.

(a)

(b)

(c)

(d)

(e)

(f)